Adding Taurolidine to Heparin Cuts Risk for Catheter-Related Bloodstream Infections
Taurolidine is an antibacterial and antifungal agent with a mechanism of action that is less prone to development of antimicrobial resistance.
Taurolidine is an antibacterial and antifungal agent with a mechanism of action that is less prone to development of antimicrobial resistance.
Use of analog vs human insulin in patients receiving hemodialysis is associated with a lower risk for major adverse cardiovascular events, hospitalization, and death.
In a study, patients undergoing thrice-weekly extended home hemodialysis had a lower death risk compared with those receiving in-center conventional hemodialysis.
Researchers evaluated the link between diabetic retinopathy and macrovascular complications in patients undergoing hemodialysis.
Growth differentiation factor-15 predicts major bleeding, major adverse cardiac events, and mortality in patients on hemodialysis.
Clinicians are asking whether sodium-glucose cotransporter 2 inhibitors can be continued in patients with kidney failure for their purported cardiovascular benefits.
Differences between the dialysis and nondialysis population were most pronounced during the first Omicron wave, investigators reported.
Study findings lend support to placing “the right access in the right patient at the right time” per the 2019 KDOQI guideline rather than using a strict “fistula first” approach.
Study findings highlight a need to implement early interventions to reduce frailty after hemodialysis initiation.
Study finds age-, sex-, race and ethnicity-, and social deprivation-related disparities in the timing of preoperative hemodialysis.